Healthy men needed to track how new drug moves through the body
NCT ID NCT06572111
First seen Oct 31, 2025
Summary
This early-stage study looked at how healthy men absorb, break down, and eliminate the experimental drug BI 1839100. The trial had two parts: one measured how much of the drug and its radioactive tracer was recovered in urine and stool after an oral dose, and the other compared drug levels in the blood after oral versus IV dosing. The study was terminated early and involved only 8 participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ICON-Groningen-62040
Groningen, 9728 NZ, Netherlands
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.